0.613
0.61 (0%)
As of Dec 20, 2024
Lyell Immunopharma, Inc. [LYEL]
Source:
Company Overview
Lyell Immunopharma, Inc is a clinical-stage cell therapy company advancing a pipeline of product candidates for patients with solid tumors utilizing our proprietary ex vivo genetic and epigenetic T‑cell reprogramming technologies.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 650 695-0677 |
| Industry | |
| CEO | Lynn Seely |
| Website | www.lyell.com |